Journal
CLINICAL RHEUMATOLOGY
Volume 42, Issue 2, Pages 597-606Publisher
SPRINGER LONDON LTD
DOI: 10.1007/s10067-022-06465-9
Keywords
Amyloidosis; HMOX-1; Inflammation; Serum amyloid A
Categories
Ask authors/readers for more resources
In this study, we report a case of AA-type renal amyloidosis in a young male, which was caused by a chronic inflammatory condition possibly due to HMOX-1 deficiency. Clinical exome sequencing confirmed the diagnosis of HMOX-1 deficiency related to a homozygous missense G139V mutation. To the best of our knowledge, this is the eleventh case of HMOX-1 deficiency reported in the literature and the first report of HMOX-1 deficiency-related systemic AA-type amyloidosis.
Heme oxygenase-1 (HMOX-1) is an enzyme that regulates heme degradation. Antiinflammatory, antioxidant, and cytoprotective effects of HMOX-1 were also described. It is encoded by the HMOX1 gene, and biallelic mutations cause HMOX-1 deficiency, which is a rare chronic multisystemic inflammatory disorder. This inflammatory status could lead to the development of secondary AA-type amyloidosis theoretically. Here, we report a 30-year-old male with AA-type renal amyloidosis due to a chronic inflammatory condition of unknown origin. Paternal consanguinity and dysmorphic features raised suspicion of a rare genetic disorder. Clinical exome sequencing (CES) confirmed the HMOX-1 deficiency diagnosis related to homozygous missense G139V mutation. To the best of our knowledge, our patient is the eleventh HMOX-1 deficiency case in the literature. Also, HMOX-1 deficiency-related systemic AA-type amyloidosis has not been reported before.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available